Physician profile

Meera Beharry

Adolescent Medicine (Pediatrics) · Fort Pierce, FL

NPI 1447403340

$5,066.44

in general payments reported to CMS, 2019-2025

4 companies · $4,896 in 2025

The $4,896 reported for 2025 was more than what 98% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).

See the full distribution for Adolescent Medicine (Pediatrics)

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$4,896.00
Food and Beverage$13.15

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sanofi Pasteur INC. $4,896.00 2025
Novartis Pharmaceuticals Corporation $112.02 2019
Merck Sharp & Dohme LLC $45.27 2019
Evofem Biosciences, INC. $13.15 2024

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Meera Beharry

$5,066.44

in general payments reported 2019-2025

Years
2019-2025
Top company
Sanofi Pasteur INC.
Context
The $4,896 reported for 2025 was more than what 98% of Adolescent Medicine (Pediatrics) providers received nationally (typical 2025 total: $99.31).

https://glasscript.com/doctor/974014/meera-beharry

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.